Popular on TelAve
- Mother's Day Wake-Up Call for Maternal Health: New Initiative Demands Better Postpartum Support
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
- The ROS1ders Announces Recipients of 2024 ROS1+ Cancer Innovation Awards
- $1B Target by 2027 Amid eSIM, Global Roaming Expansion; $57.6M Q1 Revenue and Market Uplisting, Advancing Toward IQSTEL, Inc. (Stock Symbol: IQST)
- Bold Beauty Project UCLA Edition Photography Exhibition on May 18
- GTS Acquires AMT Telecom Group, Strengthening Leadership in Technology Solutions Distribution
- LIB TH-50/TH-80 Benchtop Environmental Chamber Drives Global Demand
- Natalie Jean Releases Heartfelt Tribute Single "What They Didn't See" Honoring Late Friend and Lyricist Michael Peloso
- Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
- Industrial Parts Fittings Champions the Revival of American Manufacturing
Similar on TelAve
- Kaplan Morrell Applauds Passage of Landmark Workers' Compensation Reform in Colorado
- $750 Million Market Projected to Reach $3.3 Billion Globally in 2034 for New Drug Application Filed on Preservative-Free IV Ketamine: NRx Pharma, Inc
- oneservice AG Names Andrea Steudel as CFO to Drive Global Growth and Financial Transformation
- June 2-8 is Medicare Fraud Prevention Week
- CCHR Warns: Millions of Children Exposed to Risky Psychiatric Drugs
- Chosen Launches Mobile Family Closet to Serve Foster, Adoptive, and Kinship Families Across Southeastern Wisconsin
- ARCH Dental + Aesthetics Unveils New Website for Enhanced Patient Experience
- Juventix Regenerative Medical Announces Strategic Partnership with Juvasonic® to Expand Needle-Free Biologic Delivery Platform
- Group Seeks End to Mandated Community Psychiatric Programs, Citing Global Alarm
- Mental Health Watchdog Calling for a Ban on the Use of the Electroshock Machine in Florida
Precision Antibody to Attend Antibody Engineering & Therapeutics Europe in Basel, Switzerland
TelAve News/10864574
COLUMBIA, Md. - TelAve -- Precision Antibody, a leading provider of custom monoclonal antibody development services, is pleased to announce its attendance at the upcoming Antibody Engineering & Therapeutics Europe, taking place June 10–12, 2025, at the Congress Center Basel, Switzerland.
The event, hosted by Informa Connect, is Europe's premier conference for professionals advancing antibody research, engineering, and development. It brings together scientific experts, biotech leaders, and solution providers to discuss breakthroughs in antibody discovery, therapeutic design, and clinical development.
"We're excited to engage with innovators and scientists who are shaping the future of antibody engineering," said Dr. Hayashi. "Our mission is to help researchers accelerate discovery by providing high-quality, high-specificity monoclonal antibodies that deliver reliable results, every time."
Precision Antibody's proven expertise in generating antibodies that work "right the first time" has made it a trusted partner for biopharma and academic researchers worldwide. Attendees at Antibody Engineering & Therapeutics Europe are invited to connect with the Precision Antibody team to explore how their antibody solutions can streamline discovery workflows and advance therapeutic development.
More on TelAve News
About Precision Antibody
Founded in 2000, Precision Antibody is a U.S.-based biotechnology company specializing in the development of high-affinity, high-specificity monoclonal antibodies. With a commitment to speed, quality, and reliability, Precision Antibody empowers researchers across academia, biotechnology, and the pharmaceutical industry to achieve scientific breakthroughs more quickly.
Media Contact:
Precision Antibody
Dr. Jun Hayashi
President
Phone: 410-884-4100
Email: info@precisionantibody.com
Website: www.precisionantibody.com
Event Details:
Antibody Engineering & Therapeutics Europe
Dates: June 10 - 12, 2025
Venue: Congress Center, Basel, Switzerland
Event Website: https://informaconnect.com/antibody-engineering-europe/
The event, hosted by Informa Connect, is Europe's premier conference for professionals advancing antibody research, engineering, and development. It brings together scientific experts, biotech leaders, and solution providers to discuss breakthroughs in antibody discovery, therapeutic design, and clinical development.
"We're excited to engage with innovators and scientists who are shaping the future of antibody engineering," said Dr. Hayashi. "Our mission is to help researchers accelerate discovery by providing high-quality, high-specificity monoclonal antibodies that deliver reliable results, every time."
Precision Antibody's proven expertise in generating antibodies that work "right the first time" has made it a trusted partner for biopharma and academic researchers worldwide. Attendees at Antibody Engineering & Therapeutics Europe are invited to connect with the Precision Antibody team to explore how their antibody solutions can streamline discovery workflows and advance therapeutic development.
More on TelAve News
- TEDxInglewood Returns to The Miracle Theater on August 9, 2025 — Celebrating Bold Ideas and Community Energy
- No Limits Method Revolutionizes Neurodivergent Education Through Embodied Cognition
- Manhattan Boutique Real Estate Collaborates with InterContinental Hotels NYC in a Branding Partners Personalized Approach
- First AI Marketing Platform Built Specifically for Small Businesses Launches Public Beta
- Kaplan Morrell Applauds Passage of Landmark Workers' Compensation Reform in Colorado
About Precision Antibody
Founded in 2000, Precision Antibody is a U.S.-based biotechnology company specializing in the development of high-affinity, high-specificity monoclonal antibodies. With a commitment to speed, quality, and reliability, Precision Antibody empowers researchers across academia, biotechnology, and the pharmaceutical industry to achieve scientific breakthroughs more quickly.
Media Contact:
Precision Antibody
Dr. Jun Hayashi
President
Phone: 410-884-4100
Email: info@precisionantibody.com
Website: www.precisionantibody.com
Event Details:
Antibody Engineering & Therapeutics Europe
Dates: June 10 - 12, 2025
Venue: Congress Center, Basel, Switzerland
Event Website: https://informaconnect.com/antibody-engineering-europe/
Source: Precision Antibody
0 Comments
Latest on TelAve News
- The best free cloud mining platform certified by the UK, helping you to easily earn profits
- Conexwest Unveils 20ft Ground-Level Mobile Office Container with Integrated Restroom
- Western Carolina Emergency Network Accepts 2025 ReadyCommunities Partnership/CCROA National Service Award for Collaboration to Augment Local Response
- Pregis Empowers Foam-in-Place Customers to Fight Water Insecurity with Inspyre Film
- Elliott Entertainment LLC & GCI Film Present Dionne Warwick At NYC's Apollo Theater "Don't Make Me Over, One Night Only", June 27th, 2025
- Fusion Marketing Group Celebrates 15 Years of Transforming Healthcare Recruitment Marketing
- Century Fasteners Corp. Exhibiting at the 2025 International Paris Air Show
- The World's No.1 Superstar™ Silences His Own Husband with Legally Binding NDA — "Call Him Mr. Sidow Sobrino" Now Law
- TRICOR Insurance Earns 2025 Great Place To Work Certification™
- Power Up Church Launches "The Power Core": A Bold New Giving Model Energizing Real-World Impact
- Broadway Icon Laura Bell Bundy Joins Mahaffey Summer Camp for Special One-Night Event
- Levitt Pavilion Los Angeles Summer Concert Series 2025
- Potential Short Squeeze Following Successful Exposure at Detroit Grand Prix; $100 Million Financing for Major Acquisition and Growth; Lottery.com Inc
- Shelter Structures America Appoints Shannon Heller as New Inventory Manager, Bolstering Operational Excellence in the Commercial Tent Industry
- Handel's Ice Cream Celebrates Grand opening Event in Rialto, California
- oneservice AG Names Andrea Steudel as CFO to Drive Global Growth and Financial Transformation
- Custom Android TV Box & OTT TV Box Solutions with PCBA and Mold Design Expertise
- Pietryla PR & Marketing Introduces 'Jumpstart' Consulting Packages for B2B Communications Leaders
- Zareef Hamid Analyzes How AI is Redefining Financial Services
- L2uMA Outreach Program to Support Mobile Healthcare Expansion for 65+ Population